Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism

por Gunter, Jennifer H., Kruithof-de Julio, Marianna, Zoni, Eugenio
Publicado 2022

Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models

por Wang, Nan Fang, Jue, Toni Rose, Holst, Jeff, Gunter, Jennifer H.
Publicado 2022

New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication

por Gunter, Jennifer H., Sarkar, Phoebe L., Lubik, Amy A., Nelson, Colleen C.
Publicado 2013

Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism

por Subramaniam, Sugarniya, Jeet, Varinder, Gunter, Jennifer H., Clements, Judith A., Batra, Jyotsna
Publicado 2021

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer

por Gunter, Jennifer H., Lubik, Amy A., McKenzie, Ian, Pollak, Michael, Nelson, Colleen C.
Publicado 2012

Provider Decisions and Patient Outcomes After Premature Metformin Discontinuation

por Bradley, Jessica N., Edwards, Krystal L., Gunter, Jennifer T., Weideman, Rick A., Kelly, Kevin C.
Publicado 2017

Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation

por Khan, Tashbib, Sullivan, Mitchell A., Gunter, Jennifer H., Kryza, Thomas, Lyons, Nicholas, He, Yaowu, Hooper, John D.
Publicado 2020

The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer

por Sadowski, Martin C., Pouwer, Rebecca H., Gunter, Jennifer H., Lubik, Amy A., Quinn, Ronald J., Nelson, Colleen C.
Publicado 2014

Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours

por Bhatia, Sugandha, Gunter, Jennifer H, Burgess, Joshua T, Adams, Mark N, O'Byrne, Kenneth, Thompson, Erik W, Duijf, Pascal HG
Publicado 2023

Different Characteristics and Nucleotide Binding Properties of Inosine Monophosphate Dehydrogenase (IMPDH) Isoforms

por Thomas, Elaine C., Gunter, Jennifer H., Webster, Julie A., Schieber, Nicole L., Oorschot, Viola, Parton, Robert G., Whitehead, Jonathan P.
Publicado 2012

Bcl‐2 inhibitors enhance FGFR inhibitor‐induced mitochondrial‐dependent cell death in FGFR2‐mutant endometrial cancer

por Packer, Leisl M., Stehbens, Samantha J., Bonazzi, Vanessa F., Gunter, Jennifer H., Ju, Robert J., Ward, Micheal, Gartside, Michael G., Byron, Sara A., Pollock, Pamela M.
Publicado 2019

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2

por Sarkar, Phoebe L., Lee, Wendy, Williams, Elizabeth D., Lubik, Amy A., Stylianou, Nataly, Shokoohmand, Ali, Lehman, Melanie L., Hollier, Brett G., Gunter, Jennifer H., Nelson, Colleen C.
Publicado 2019

The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype

por Thomas, Patrick B., Jeffery, Penny, Gahete, Manuel D., Whiteside, Eliza, Walpole, Carina, Maugham, Michelle, Jovanovic, Lidija, Gunter, Jennifer, Williams, Elizabeth, Nelson, Colleen, Herington, Adrian, Luque, Raul M., Veedu, Rakesh, Chopin, Lisa K., Seim, Inge
Publicado 2021

Isomeric lipid signatures reveal compartmentalized fatty acid metabolism in cancer

por Young, Reuben S.E., Bowman, Andrew P., Tousignant, Kaylyn D., Poad, Berwyck L.J., Gunter, Jennifer H., Philp, Lisa K., Nelson, Colleen C., Ellis, Shane R., Heeren, Ron M.A., Sadowski, Martin C., Blanksby, Stephen J.
Publicado 2022

A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome

por Stylianou, Nataly, Lehman, Melanie L., Wang, Chenwei, Fard, Atefeh Taherian, Rockstroh, Anja, Fazli, Ladan, Jovanovic, Lidija, Ward, Micheal, Sadowski, Martin C., Kashyap, Abhishek S., Buttyan, Ralph, Gleave, Martin E., Westbrook, Thomas F., Williams, Elizabeth D., Gunter, Jennifer H., Nelson, Colleen C., Hollier, Brett G.
Publicado 2018

Correction: A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome

por Stylianou, Nataly, Lehman, Melanie L., Wang, Chenwei, Fard, Atefeh Taherian, Rockstroh, Anja, Fazli, Ladan, Jovanovic, Lidija, Ward, Micheal, Sadowski, Martin C., Kashyap, Abhishek S., Buttyan, Ralph, Gleave, Martin E., Westbrook, Thomas F., Williams, Elizabeth D., Gunter, Jennifer H., Nelson, Colleen C., Hollier, Brett G.
Publicado 2018

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma

por Khan, Tashbib, He, Yaowu, Kryza, Thomas, Harrington, Brittney S., Gunter, Jennifer H., Sullivan, Mitchell A., Cuda, Tahleesa, Rogers, Rebecca, Davies, Claire M., Broomfield, Amy, Gough, Madeline, Wu, Andy C., McGann, Thomas, Weroha, S. John, Haluska, Paul, Forbes, Josephine M., Armes, Jane E., Barry, Sinead C., Coward, Jermaine I., Jagasia, Nisha, Chetty, Naven, Snell, Cameron E., Lourie, Rohan, Perrin, Lewis C., Hooper, John D.
Publicado 2020